Ledger.Open graph →

SEC Form D · filed February 17, 2023

KIORA PHARMACEUTICALS INC

Offering

$10.0M

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

ENCINITAS, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Brian Strem · Encinitas, CAExec · Director David Hollander · Encinitas, CADirector Eric Daniels · Encinitas, CAExec Aron Shapiro · Encinitas, CADirector Melissa Tosca · Encinitas, CAExec Erin Parsons · Encinitas, CADirector Paul Chaney · Encinitas, CADirector Praveen Tyle · Encinitas, CADirector Kenneth Gayron · Encinitas, CADirector Matt F. Van Fleet · CINCINNATI, OHExec · Director Bridgeport Management Services, LLC · Cardiff, CAExec Stephen Chavez · Springfield, MODirector Anthony Shaskus · New York, NYDirector Pamela J. Pure · CENTENNIAL, CODirector John Illuzzi · New York, NYDirector Kyle M. Maierhofer · CENTENNIAL, COExec Van Nguyen · New York, NYDirector Thomas K. Hearn · CENTENNIAL, CODirector Steven Coffey · Sydney, Channel IslandsExec · Director John Friend · Sydney, Channel IslandsExec Jeffrey Bonacorda · Sydney, Channel IslandsDirector Robert Apple · Sydney, Channel IslandsDirector Ebru Davidson · Sydney, Channel IslandsDirector Bryce Carmine · Sydney, Channel IslandsDirector Elissa Hansen · Sydney, Channel IslandsDirector Jeannine Davison · Vista, CADirector Robert Gunn · PORTLAND, ORExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗